Stay updated on Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.

Latest updates to the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page
- Check7 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record content. This indicates an access or server issue that prevents viewing the study details on this page.SummaryDifference19%

- Check49 days agoChange DetectedThe page adds a funding reference (2016 NIH Grant/Contract) and updates the site revision tag to v3.6.6, reflecting funding attribution and a software version change.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision label on the page updated from v3.6.4 to v3.6.5. This reflects an internal release update and does not alter the study content or user-facing features.SummaryDifference0.0%

- Check84 days agoChange DetectedA new Revision: v3.6.4 entry appears, replacing Revision: v3.6.3. This indicates a minor version update to the page's metadata, not impacting study content or functionality.SummaryDifference0.0%

- Check106 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor update to the study record documentation on the page.SummaryDifference0.0%

Stay in the know with updates to Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.